Pharmaceutically acceptable salts and crystalline forms of GLP-1 receptor agonists and methods for preparing same
JP2024547113APending Publication Date: 2024-12-26JIANGSU HENGRUI MEDICINE CO LTD +1
Patent Information
- Application Number
- JP2024537986
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-23
- Filing Date
- 2022-12-23
- Publication Date
- 2024-12-26
Smart Images

Figure 2024547113000026 
Figure 2024547113000027 
Figure 2024547113000028
Abstract
The present invention provides a pharma- ceutically acceptable salt of a GLP-1 receptor agonist, a crystalline form thereof, and a method for preparing the same. Specifically, the present invention provides a pharma- ceutically acceptable salt of the compound 2-((4-((S)-3-(4-chloro-2-fluorophenyl)-2,3-dihydrobenzo[b][1,4]dioxan-5-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid and a crystalline form thereof.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
GLP-1 receptor agonists and uses thereof
JP2021521265A
Crystalline forms of GLP-1 receptor agonists and methods for preparing same
JP2024547112A
Fused imidazole derivatives, their preparation method and their pharmaceutical applications
JP7812052B2
GLP-1r agonists and uses thereof
WO2020103815A1
Methyl-substituted benzobisoxazole compound and use thereof
WO2021249492A1
Cited By
Crystalline forms of GLP-1 receptor agonists and methods for preparing same
JP2024547112A
